Early studies on LC using a human hepatocellular carcinoma cell line (Hep G2 cells) revealed that both slc1a5 promoter activity and the protein expression of ASCT2 were dependent on the presence of Gln. Here, SLC1A5 is linked to laryngotracheoesophageal cleft.